Immune Signaling Pathway Protects Newborn Heart Cells From Injury

Researchers investigating cardiac tissue recovery have identified an immune signaling pathway that protects newborn heart cells from injury, revealing a biological mechanism that could ultimately inform future regenerative therapies for … Read More

Microbial Metabolites May Improve Hepatitis B Functional Cures

Recent gastroenterology and immunology findings indicate that specific microbial metabolites can significantly enhance functional cure rates for chronic hepatitis B virus (HBV) infection. Published in medical journals, this research illuminates … Read More

Pediatric Endocrinology Research: University of Florida and Princess Máxima Center

Setmelanotide, a melanocortin-4 receptor (MC4R) agonist, is currently being investigated for the treatment of acquired hypothalamic obesity, a rare condition caused by physical damage to the hypothalamus. By targeting the … Read More

Experimental CAR T-Cell Therapy Shows Promise Against Solid Tumors

Experimental CAR T-cell therapy has demonstrated efficacy in treating solid tumors, according to clinical data reported by News-Medical this week. The first-in-class treatment modifies a patient’s own T-cells to recognize … Read More

Light-Controlled Molecular Switch Enhances Lung Cancer Treatment

Scientists have developed a light-activated molecular switch that selectively “wakes” dormant lung cancer cells, making them vulnerable to targeted therapies—potentially doubling treatment response rates in early-stage trials. The breakthrough, published … Read More

Weight Loss Drugs Linked to Lower Breast Cancer Risk

Recent large-scale cohort studies indicate that glucagon-like peptide-1 (GLP-1) receptor agonists, primarily used for weight management and type 2 diabetes, are associated with a reduced incidence of several obesity-related cancers. … Read More

New Guidelines for Identifying and Treating High-Risk IEC-HS Patients

New global guidelines, published this week in the Journal of Hepatology, redefine how clinicians identify and treat high-risk patients with iron overload from hereditary hemochromatosis (IEC-HS)—a genetic disorder where excessive … Read More